$LRMR·4

ZAFGEN, INC. · May 15, 8:22 PM ET

ZAFGEN, INC. 4

4 · ZAFGEN, INC. · Filed May 15, 2017

Insider Transaction Report

Form 4
Period: 2017-05-11
Hughes Thomas E.
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-05-11$0.75/sh+18,928$14,19683,088 total
  • Exercise/Conversion

    Common Stock

    2017-05-11$0.75/sh+6,210$4,65889,298 total
  • Exercise/Conversion

    Common Stock

    2017-05-11$0.82/sh+68,073$55,820157,371 total
  • Exercise/Conversion

    Stock Option (Right to Buy

    2017-05-1118,9280 total
    Exercise: $0.75Exp: 2018-12-15Common Stock (18,928 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-116,2100 total
    Exercise: $0.75Exp: 2019-03-18Common Stock (6,210 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-05-1168,0730 total
    Exercise: $0.82Exp: 2020-03-10Common Stock (68,073 underlying)
Footnotes (2)
  • [F1]Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017.
  • [F2]Fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION